Showing results (191-200 of 535) with videos related to

Sort By:
Pageof 54
Bone Marrow Transplantation|November 1, 1993
Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remissionH Martin, J Bruecher, R Claudé, et al.
Anticancer Research|January 19, 1999
Advanced head and neck cancer and clinical experience of an effective new agent: docetaxelP Schöffski, T Weihkopf, A Ganser
Der Internist|November 9, 2013
[Therapy of multiple myeloma. What is confirmed?]D Peest, A Ganser, H Einsele
Stem Cells (Dayton, Ohio)|January 1, 1997
IL-3 in the clinicM Eder, G Geissler, A Ganser
Der Internist|February 22, 2015
[Myelodysplastic syndromes]F Thol, M Heuser, A Ganser
Annals of Hematology|March 5, 1998
Effect of stimulation by interferon gamma and tumor necrosis factor alpha on CD54 expression and homotypic aggregation of blasts of acute lymphoblastic leukemiasJ Krauter, A Ganser, G Heil
Acta Haematologica|January 1, 1983
Cytogenetic studies in chronic myeloproliferative disordersF Carbonell, A Ganser, H Heimpel
Hematology (Amsterdam, Netherlands)|July 16, 2016
The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual DiseaseJ Krauter, G Heil, A Ganser
Bone Marrow Transplantation|December 1, 1999
Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis - are there new strategies?M Karthaus, C Rosenthal, A Ganser
Annals of Hematology|February 9, 2000
Intensive chemotherapy with idarubicin, ara-C, etoposide, and m-AMSA followed by immunotherapy with interleukin-2 for myelodysplastic syndromes and high-risk Acute Myeloid Leukemia (AML)A Ganser, G Heil, G Seipelt, et al.
Pageof 54